109 related articles for article (PubMed ID: 36105891)
1. Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain.
Zhou X; Zhao J; Qiu Y; Jia R
Biosaf Health; 2022 Oct; 4(5):293-298. PubMed ID: 36105891
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
3. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
Low-Gan J; Huang R; Warner G; Kelley A; McGregor D; Smider V
bioRxiv; 2020 Nov; ():. PubMed ID: 33140054
[TBL] [Abstract][Full Text] [Related]
4. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
5. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
6. A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.
Li J; Ma X; Guo S; Hou C; Shi L; Zhang H; Zheng B; Liao C; Yang L; Ye L; He X
Glob Chall; 2020 Dec; 4(12):2000067. PubMed ID: 33173592
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
8. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
9. Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2.
Bhattacharjee MJ; Lin JJ; Chang CY; Chiou YT; Li TN; Tai CW; Shiu TF; Chen CA; Chou CY; Chakraborty P; Tseng YY; Wang LH; Li WH
Mol Biol Evol; 2021 Jun; 38(7):2715-2731. PubMed ID: 33674876
[TBL] [Abstract][Full Text] [Related]
10. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
[TBL] [Abstract][Full Text] [Related]
11. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV
Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627
[TBL] [Abstract][Full Text] [Related]
12. The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
Li JY; Wang Q; Liao CH; Qiu Y; Ge XY
Virus Res; 2021 Apr; 295():198307. PubMed ID: 33476695
[TBL] [Abstract][Full Text] [Related]
13. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
14. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
[TBL] [Abstract][Full Text] [Related]
15. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
16. The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2.
Li HY; Gao N; Liu CY; Liu XL; Wu F; Dai N; Han J; Li QY
Front Immunol; 2022; 13():918731. PubMed ID: 35874670
[TBL] [Abstract][Full Text] [Related]
17. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
18. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
19. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site.
Buonocore M; Santoro A; Grimaldi M; Covelli V; Firoznezhad M; Rodriquez M; Santin M; D'Ursi AM
Heliyon; 2022 Nov; 8(11):e11568. PubMed ID: 36406731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
